(Q44768744)

6 December 2017

0 references

Prepulse inhibition and habituation of acoustic startle response in male MDMA ('ecstasy') users, cannabis users, and healthy controls (English)

1 reference

6 December 2017

1

1 reference

6 December 2017

4

Wolfgang Maier

1 reference

6 December 2017

5

Michael Wagner

0 references

author name string

Kai-Uwe Kühn

series ordinal

2

1 reference

PubMed ID

14970829

6 December 2017

Klaus Hoenig

series ordinal

3

1 reference

PubMed ID

14970829

6 December 2017

language of work or name

English

0 references

publication date

1 May 2004

1 reference

6 December 2017

Neuropsychopharmacology

1 reference

6 December 2017

29

1 reference

6 December 2017

5

1 reference

6 December 2017

982-990

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.npp.1300396

6 December 2017

0 references

cites work

MDMA ('Ecstasy') enhances 5-HT1A receptor density and 8-OH-DPAT-induced hypothermia: blockade by drugs preventing 5-hydroxytryptamine depletion.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300396

Oral administration of 3,4-methylenedioxymethamphetamine (MDMA) produces selective serotonergic depletion in the nonhuman primate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300396

MDMA-induced neurotoxicity: parameters of degeneration and recovery of brain serotonin neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300396

Depletion of brain serotonin differently affects behaviors induced by 5HT1A, 5HT1C, and 5HT2 receptor activation in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300396

Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300396

Gating and habituation of the startle reflex in schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300396

Attenuated habituation due to parachlorophenylalanine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300396

Sensorimotor gating in boys with Tourette's syndrome and ADHD: preliminary results.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300396

Amphetamine designer drugs - an overview and epidemiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300396

Parachlorophenylalanine and habituation to repetitive auditory startle stimuli in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300396

The relative contributions of ecstasy and cannabis to cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300396

Is MDMA ('Ecstasy') neurotoxic in humans? An overview of evidence and of methodological problems in research

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300396

Psychological profile of abstinent recreational Ecstasy (MDMA) users and significance of concomitant cannabis use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300396

p-Chloroamphetamine (PCA): Acute and chronic effects on habituation and sensitization of the acoustic startle response in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300396

Habituation and sensitization of startle reflexes elicited electrically from the brainstem.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300396

Reduced brain serotonin activity disrupts prepulse inhibition of the acoustic startle reflex. Effects of 5,7-dihydroxytryptamine and p-chlorophenylalanine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300396

Startle habituation and sensorimotor gating in schizophrenia and related animal models

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300396

Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300396

Habituation of tactile startle is altered by drugs acting on serotonin-2 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300396

Neuroendocrine abnormalities in recreational ecstasy (MDMA) users: is it ecstasy or cannabis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300396

Chronic neurotoxic damage in ecstasy (MDMA) users. Review of the current state of research

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300396

Presidential Address, 1974. The more or less startling effects of weak prestimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300396

Habituation: a dual-process theory.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300396

Abstinence symptoms following smoked marijuana in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300396

Prepulse inhibition of acoustic startle, a measure of sensorimotor gating: effects of antipsychotics and other agents in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300396

5-HT modulation of auditory and visual sensorimotor gating: I. Effects of 5-HT releasers on sound and light prepulse inhibition in Wistar rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300396

How strong is the evidence that brain serotonin neurons are damaged in human users of ecstasy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300396

The neurobiology of startle

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300396

Effects of MDMA (ecstasy) on prepulse inhibition and habituation of startle in humans after pretreatment with citalopram, haloperidol, or ketanserin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300396

Prepulse inhibition of the acoustic startle response is disrupted by N-ethyl-3,4-methylenedioxyamphetamine (MDEA) in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300396

Effects of the cannabinoid CB1 receptor antagonist SR141716A on the behavior of pigeons and rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300396

Effects of cannabinoid receptor ligands on psychosis-relevant behavior models in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300396

Characterization of the disruptions of prepulse inhibition and habituation of startle induced by alpha-ethyltryptamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300396

(+/-)3,4-Methylenedioxymethamphetamine ('Ecstasy')-induced serotonin neurotoxicity: clinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300396

Cognitive performance in (+/-) 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") users: a controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300396

Serotonin neurotoxicity after (+/-)3,4-methylenedioxymethamphetamine (MDMA; "Ecstasy"): a controlled study in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300396

Increased anxiety 3 months after brief exposure to MDMA ("Ecstasy") in rats: association with altered 5-HT transporter and receptor density

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300396

Long-term neuropsychiatric consequences of "ecstasy" (MDMA): a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300396

Ecstasy (MDMA): a review of its possible persistent psychological effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300396

Human research on MDMA (3,4-methylene- dioxymethamphetamine) neurotoxicity: cognitive and behavioural indices of change

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300396

Human psychopharmacology of Ecstasy (MDMA): a review of 15 years of empirical research

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300396

Ecstasy (MDMA) effects upon mood and cognition: before, during and after a Saturday night dance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300396

Depletion of 5-HT disrupts prepulse inhibition in rats: dependence on the magnitude of depletion, and reversal by a 5-HT precursor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300396

Pharmacological evidence of supersensitivity of central serotonergic receptors involved in the control of prolactin secretion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300396

The acute and chronic effects of MDMA ("ecstasy") on cortical 5-HT2A receptors in rat and human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300396

The molecular mechanism of "ecstasy" [3,4-methylenedioxy-methamphetamine (MDMA)]: serotonin transporters are targets for MDMA-induced serotonin release

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300396

The cannabinoid agonist WIN 55,212-2 reduces sensorimotor gating and recognition memory in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300396

Differing effects of the cannabinoid agonist, CP 55,940, in an alcohol or Tween 80 solvent, on prepulse inhibition of the acoustic startle reflex in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300396

The effects of 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxyamphetamine (MDA) on monoaminergic systems in the rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300396

Cross-species studies of sensorimotor gating of the startle reflex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300396

Tactile prepuff inhibition of startle in children with Tourette's syndrome: in search of an "fMRI-friendly" startle paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300396

Functional consequences of repeated (+/-)3,4-methylenedioxymethamphetamine (MDMA) treatment in rhesus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300396

Opposite effects of 3,4-methylenedioxymethamphetamine (MDMA) on sensorimotor gating in rats versus healthy humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300396

(-)Alprenolol potentiates the disrupting effects of dizocilpine on sensorimotor function in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300396

Methylenedioxymethamphetamine induces opposite changes in central pre- and postsynaptic 5-HT1A receptors in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300396

7 January 2021

Effects of the hallucinogen psilocybin on habituation and prepulse inhibition of the startle reflex in humans.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300396

7 January 2021

Acoustic and temporal factors in the evocation of startle

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300396

7 January 2021

Urinary excretion half-life of 11-nor-9-carboxy-delta9-tetrahydrocannabinol in humans

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300396

7 January 2021

Effects of acute tryptophan depletion on prepulse inhibition of the acoustic startle (eyeblink) response and the N1/P2 auditory evoked response in man

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300396

7 January 2021

(+) 3,4-methylenedioxymethamphetamine ('ecstasy') transiently increases striatal 5-HT1B binding sites without altering 5-HT1B mRNA in rat brain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300396

7 January 2021

A preliminary assessment of sensorimotor gating in patients with obsessive compulsive disorder

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300396

7 January 2021

Distinct morphologic classes of serotonergic axons in primates exhibit differential vulnerability to the psychotropic drug 3,4-methylenedioxymethamphetamine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300396

7 January 2021

Identifiers

DOI

10.1038/SJ.NPP.1300396

1 reference

6 December 2017

1 reference

PubMed ID

14970829